|
|
Developmental neurotoxicity and autism spectrum disorder |
| 1K43TW011920-01A1 |
|
FIC |
2022 |
|
|
Mechanisms of prenatal opioid exposure on brain and behavior |
| 1R01DA050871-01A1 |
|
NIDA |
2022 |
|
|
Prenatal Tobacco Exposure: Self-Regulatory Pathways to Externalizing Behaviors |
| 5K01DA048135-03 |
|
NIDA |
2022 |
|
|
MRI data fusion to investigate effects of drug abuse on HIV neurological complications |
| 5R01DA045565-05 |
|
NIDA |
2022 |
|
|
Emotional Systems in Attention-Deficit/Hyperactivity Disorder |
| 1 D43 TW012027-01A1 |
MUSCH, DAVID C |
FIC |
2021 |
|
|
Facilitating supervised self-management of stimulant medications among adolescents: improving adherence, reducing stigma, and supporting caregivers |
| 1 R43 DA053121-01A1 |
PERSE, ARTIN |
NIDA |
2021 |
|
|
Prenatal Tobacco Exposure: Self-Regulatory Pathways to Externalizing Behaviors |
| 5 K01 DA048135-02 |
MICALIZZI, LAUREN GIOIA |
NIDA |
2021 |
|
|
Early Stress and the Neurobiology of Susceptibility and Resilience to Substance Use Disorders |
| 5 R01 DA017846-12 |
TEICHER, MARTIN H |
NIDA |
2021 |
|
|
Neuronal Adaptation and Plasticity after Chronic Disuse |
| 2R01MH071739-17 |
TSIEN, RICHARD W |
NIDA |
2020 |
|
|
DEVELOPMENT OF A COMMERCIAL PLATFORM FOR DISCOVERY AND VALIDATION OF KEY MICROBIAL METABOLITES IN CNS DISORDERS |
| 4R44DA043954-02 |
IWAI, SHOKO |
NIDA |
2019 |